[go: up one dir, main page]

AU2003217357A1 - Generation of new insulin cells from progenitor cells present in adult pancreatic islets - Google Patents

Generation of new insulin cells from progenitor cells present in adult pancreatic islets

Info

Publication number
AU2003217357A1
AU2003217357A1 AU2003217357A AU2003217357A AU2003217357A1 AU 2003217357 A1 AU2003217357 A1 AU 2003217357A1 AU 2003217357 A AU2003217357 A AU 2003217357A AU 2003217357 A AU2003217357 A AU 2003217357A AU 2003217357 A1 AU2003217357 A1 AU 2003217357A1
Authority
AU
Australia
Prior art keywords
generation
pancreatic islets
cells
new insulin
adult pancreatic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003217357A
Other versions
AU2003217357A8 (en
Inventor
Teitelman Gladys
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Foundation of the State University of New York
Original Assignee
Research Foundation of the State University of New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Foundation of the State University of New York filed Critical Research Foundation of the State University of New York
Publication of AU2003217357A8 publication Critical patent/AU2003217357A8/en
Publication of AU2003217357A1 publication Critical patent/AU2003217357A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/34—Sugars

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2003217357A 2002-02-07 2003-02-07 Generation of new insulin cells from progenitor cells present in adult pancreatic islets Abandoned AU2003217357A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35571502P 2002-02-07 2002-02-07
US60/355,715 2002-02-07
PCT/US2003/003859 WO2003066832A2 (en) 2002-02-07 2003-02-07 Generation of new insulin cells from progenitor cells present in adult pancreatic islets

Publications (2)

Publication Number Publication Date
AU2003217357A8 AU2003217357A8 (en) 2003-09-02
AU2003217357A1 true AU2003217357A1 (en) 2003-09-02

Family

ID=27734554

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003217357A Abandoned AU2003217357A1 (en) 2002-02-07 2003-02-07 Generation of new insulin cells from progenitor cells present in adult pancreatic islets

Country Status (2)

Country Link
AU (1) AU2003217357A1 (en)
WO (1) WO2003066832A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7875272B2 (en) 2003-06-27 2011-01-25 Ethicon, Incorporated Treatment of stroke and other acute neuraldegenerative disorders using postpartum derived cells
AU2004252571C1 (en) 2003-06-27 2012-03-01 Ethicon, Incorporated Postpartum-derived cells for use in treatment of disease of the heart and circulatory system
US9592258B2 (en) 2003-06-27 2017-03-14 DePuy Synthes Products, Inc. Treatment of neurological injury by administration of human umbilical cord tissue-derived cells
US9572840B2 (en) 2003-06-27 2017-02-21 DePuy Synthes Products, Inc. Regeneration and repair of neural tissue using postpartum-derived cells
US8790637B2 (en) 2003-06-27 2014-07-29 DePuy Synthes Products, LLC Repair and regeneration of ocular tissue using postpartum-derived cells
WO2006071802A2 (en) 2004-12-23 2006-07-06 Ethicon Incorporated Treatment of stroke and other acute neural degenerative disorders using postpartum derived cells
PL1971681T3 (en) 2005-12-16 2018-01-31 Depuy Synthes Products Inc Compositions and methods for inhibiting adverse immune response in histocompatibility-mismatched transplantation
US9125906B2 (en) 2005-12-28 2015-09-08 DePuy Synthes Products, Inc. Treatment of peripheral vascular disease using umbilical cord tissue-derived cells
PL2379088T3 (en) 2008-12-19 2018-07-31 DePuy Synthes Products, Inc. Treatment of lung and pulmonary diseases and disorders
US10179900B2 (en) 2008-12-19 2019-01-15 DePuy Synthes Products, Inc. Conditioned media and methods of making a conditioned media
BRPI1013409A2 (en) 2009-03-26 2018-01-16 Advanced Tech And Regenerative Medicine Llc human umbilical cord tissue cells as therapy for alzheimer's disease
MX362198B (en) 2011-12-23 2019-01-08 Depuy Synthes Products Llc Detection of human umbilical cord tissue-derived cells.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5116753A (en) * 1991-07-30 1992-05-26 The Salk Institute For Biological Studies Maintenance of pancreatic islets
US5858973A (en) * 1994-02-23 1999-01-12 The General Hospital Corporation Transcription factor and uses therefor
US5958404A (en) * 1994-04-13 1999-09-28 Research Corporation Technologies, Inc. Treatment methods for disease using co-localized cells and Sertoli cells obtained from a cell line
US5916790A (en) * 1995-03-03 1999-06-29 Metabolex, Inc. Encapsulation compositions, and methods

Also Published As

Publication number Publication date
AU2003217357A8 (en) 2003-09-02
WO2003066832A3 (en) 2003-12-24
WO2003066832A2 (en) 2003-08-14

Similar Documents

Publication Publication Date Title
AU2003268534A8 (en) Cd56 positive human adult pancreatic endocrine progenitor cells
IL144654A0 (en) Pancreatic progenitor cells, methods and uses related thereto
AU2003217357A1 (en) Generation of new insulin cells from progenitor cells present in adult pancreatic islets
AU2003243212A1 (en) Improved fuel cell
AU2003298016A8 (en) Homologous recombination in multipotent adult progenitor cells
EP1585426A3 (en) Cell-seeded extracellular matrix grafts
WO2005063971A3 (en) Definitive endoderm
AU2003268200A1 (en) Bioreactors with substance injection capacity
AU2003213385A1 (en) Cell unit of solid polymeric electrolyte type fuel cell
AU2003271976A1 (en) Hydrogen fuel cell systems
AU2001264763A1 (en) Human mesenchymal progenitor cell
AU2003273574A1 (en) Intraperitoneal delivery of genetically engineered mesenchymal stem cells
AU2003302735A1 (en) Various filter elements for hydrogen fuel cell
AU2003299661A1 (en) Fuel cell assemblies and methods of making the same
AU2003217382A1 (en) FUEL CELL ELECTROCATALYST OF Pt-Rh-Mo-Ni/Fe
AU2003287114A1 (en) Alcohol-air fuel cell
AU2003266282A1 (en) Compositions comprising muscle progenitor cells and uses thereof
WO2005001042A8 (en) Smooth muscle progenitor cells
WO2003012084A3 (en) Human glucose-dependent insulin-secreting cell line
AU2003223500A1 (en) Fuel cell
AU2003231868A1 (en) Fuel cell reactant supply
AU3227000A (en) Methods of inducing insulin positive progenitor cells
AU2003221637A1 (en) Production of neural progenitor cells
AU2003257581A1 (en) Solid polymer type fuel cell
AU2003220966A1 (en) Drug containing human placenta-origin mesenchymal cells and process for producing vegf using the cells

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase